Drug Details
Therapeutic Class:
Levodopa is a central nervous system agent for dopamine replacement and carbidopa is a decarboxylase inhibitor.
Forms:
Tablet (Sinemet), capsule (Rytary), enteral suspension (Duopa)
Administration:
By mouth, by percutaneous gastrojejunostomy (PEG-J) tube
Therapeutic Uses:
Parkinson disease
Controlled Status:
Not a controlled substance
Carbidopa-Levodopa (Sinemet) Drug Class
Levodopa (lee-voh-doh-pa) is a dopamine replacement agent. Carbidopa (kar-bee-doh-pa) belongs to a group of drugs called decarboxylase inhibitors.
Carbidopa-Levodopa (Sinemet) Age Range
Carbidopa-levodopa is approved for use in adults. The safety and efficacy of this medication have not been established in pediatric patients.
SOCIAL